Pennsylvania To Expand COVID-19 Eligibility To Everyone In Phase 1C Beginning Monday
The City of Philadelphia will join the rest of Pennsylvania in opening up COVID-19 vaccines to everyone in Phase 1C on Monday.
Watch CBS News
The City of Philadelphia will join the rest of Pennsylvania in opening up COVID-19 vaccines to everyone in Phase 1C on Monday.
The neighborhood came together amid rising infection rates to ensure some hesitant seniors received critically needed shots in their arms.
Murphy got his shot at a megasite in Atlantic City, where a push is also under way to vaccinate casino workers.
The COVID-19 pandemic has brought the American cruise industry to a halt. Not a single ship has left a U.S. port with passengers in more than a year.
Dr. Michael Stephen of Jefferson Health has witnessed a year of remarkable bravery and humanity from patients, families, and hospital staff.
Pennsylvania and New Jersey are among a handful of states with the highest numbers of new COVID-19 cases.
All Philadelphians ages 16 and older will be eligible to receive their COVID-19 vaccine later this month.
President Joe Biden plans to announce Tuesday that he is moving up his deadline for states to make all American adults eligible for a coronavirus vaccine by almost two weeks.
New Jersey is opening up COVID-19 vaccine eligibility to those 16 or older beginning April 19.
Beginning Monday, Pennsylvania, New Jersey and Philadelphia are allowing more people to register for shots and we found long lines in many locations.
The city is first prioritizing these four groups: sanitation workers, maintenance and janitorial staff, utility workers and postal and delivery workers.
The plan was to vaccinate 50 people with intellectual abilities, but it wouldn't be possible without a change in city and state policies.
Updated guidance from the CDC says it's safe for fully vaccinated people to travel, but the agency says it's better not to.
Patients with serious cases of COVID-19 can end up with lung damage and there is one person from Reading who is recovering from the first lung transplant performed in Pennsylvania.
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday.
